Relative Bioavailability of Salbutamol Sulfate Controlled-Release Tablets
Qing Ge
Abstract
Qing Ge
Abstract
The pharmacokinetics and relative bioavailability of two kinds of salbutamol sulfate controlled release tablets administrated orally by 18 healthy male volunteers were investigated,according to a randomized crossover design.The plasma concentration of salbutamol was determined by RP HPLC method with fluorescence detection.The pharmacokinetic parameters for the single oral dose of 8 mg salbutamol sulfate controlled release tablets were C max 10.12±3.93 and 10.18±2.76 ng/ml; T max 5.9±1.5 and 5.8±2.2 h; T 1/2 10.5±2.5 and 9.0±2.4 h; AUC 0→∞ 155.4±30.04 and 154.4±33.17 ng·h·ml -1 ,for testing and reference tablets,respectively.The relative bioavailability for the testing tablets was 102.1%±13.94%.For the multiple dosing,the salbutamol concentration peak trough ratio(PTR) was 1.84±0.68 and 1.64±0.42,the degree of fluctuation(DF) was 25.58%± 32.00 % and 21.04%±25.25%,respectively.The results of two one sided test showed that the two kinds of salbutamol sulfate controlled release tablets were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The pharmacokinetics and relative bioavailability of two kinds of salbutamol sulfate controlled release tablets administrated orally by 18 healthy male volunteers were investigated,according to a randomized crossover design.The plasma concentration of salbutamol was determined by RP HPLC method with fluorescence detection.The pharmacokinetic parameters for the single oral dose of 8 mg salbutamol sulfate controlled release tablets were C max 10.12±3.93 and 10.18±2.76 ng/ml; T max 5.9±1.5 and 5.8±2.2 h; T 1/2 10.5±2.5 and 9.0±2.4 h; AUC 0→∞ 155.4±30.04 and 154.4±33.17 ng·h·ml -1 ,for testing and reference tablets,respectively.The relative bioavailability for the testing tablets was 102.1%±13.94%.For the multiple dosing,the salbutamol concentration peak trough ratio(PTR) was 1.84±0.68 and 1.64±0.42,the degree of fluctuation(DF) was 25.58%± 32.00 % and 21.04%±25.25%,respectively.The results of two one sided test showed that the two kinds of salbutamol sulfate controlled release tablets were bioequivalent.
Key concepts: Bioavailability, Bioequivalence, Salbutamol, Chemistry, Pharmacokinetics, Crossover study, Chromatography, Pharmacology